SIA
CORT icon

Sit Investment Associates’s Corcept Therapeutics CORT Stock Holding History

Sit Investment Associates’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-78,450
Closed -$1.05M – 538
2018
Q4 		$1.05M Hold
78,450
– – 0.03% 324
2018
Q3 		$1.1M Sell
78,450
-17,200
-18% -$240K 0.03% 324
2018
Q2 		$1.5M Hold
95,650
– – 0.04% 311
2018
Q1 		$1.57M Hold
95,650
– – 0.04% 314
2017
Q4 		$1.73M Buy
95,650
+35,250
+58% +$638K 0.04% 309
2017
Q3 		$1.17M Sell
60,400
-2,200
-4% -$32.8K 0.03% 339
2017
Q2 		$739K Buy
+62,600
New +$680K 0.02% 383

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sit Investment Associates's CORT Position: Q1 2019 in Review

Sit Investment Associates sold out of Corcept Therapeutics (CORT) in Q1 2019, closing a stake of 78,450 shares — an estimated $1.05M sold.

Sit Investment Associates first reported a position in CORT in Q2 2017 and held it in 7 quarters. The position peaked at $1.73M in Q4 2017. 208 funds tracked by Wall St. Rank hold CORT as of Q1 2019.

  • Sit Investment Associates reported no remaining Corcept Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Sit Investment Associates sold 78,450 Corcept Therapeutics shares in Q1 2019, an estimated $1.05M.
  • Sit Investment Associates first reported a position in Corcept Therapeutics in Q2 2017 and held it in 7 quarters.
  • Sit Investment Associates's Corcept Therapeutics position peaked at $1.73M in Q4 2017.
  • 208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2019.

Based on Sit Investment Associates's 13F filing for Q1 2019, filed 14 May 2019.